Introduction
IBD is a chronic systemic inflammatory disease that predominantly
involves the gastrointestinal tract. At the same time, it exerts
numerous cardiovascular manifestations, like atherosclerotic
cardiovascular disease and thromboembolic events, due to a
hypercoagulable state. Although the disease mechanism is unclear,
factors responsible, like the disruption of the normal coagulation
cascade, hyperhomocysteinemia, abnormalities in platelet-endothelial
cell interactions, and increased fibrinolysis, are implicated.